Therefore, we used the cytokines IL-1β, IL-18, and IL-6, which are all commonly found in neuroinflammation as inflammatory markers to explore the effect of treatment with GPR120-AAV-KD and GPR120-AAV-OE on neuroinflammation in epilepsy. Here, IL18 is linked to epilepsy.